<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03218527</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-ATE-2015-38</org_study_id>
    <nct_id>NCT03218527</nct_id>
  </id_info>
  <brief_title>Influence of Circulating Endothelial Progenitor Cells and Modifiable Vascular Risk Factors on Carotid Plaque Vulnerability</brief_title>
  <acronym>IMPROVE</acronym>
  <official_title>Influence of Circulating Endothelial Progenitor Cells and Modifiable Vascular Risk Factors on Carotid Plaque Vulnerability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemic stroke is a leading cause of death and disability worldwide. Atherosclerosis,
      responsible for the 20% of ischemic strokes, is characterized by lipid accumulation in the
      artery wall that leads to chronic inflammation, cell proliferation and ultimately to vessel
      stenosis. One of the main features related to plaque progression and vulnerability is
      inflammation. Positron emission tomography with 18-fluorodeoxyglucos (18-FDG PET) allows an
      accurate quantification of plaque inflammation and it has been proved its usefulness in
      predicting early stroke recurrences. The investigators aim to test how modifiable vascular
      risk factors influence plaque inflammation assessed by 18-FDG PET. In addition, investigators
      will assess the association of this inflammation and circulating endothelial progenitor cells
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 1, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Change in the Standardized Uptake Value (SUV) of the internal carotid artery</measure>
    <time_frame>Baseline and at one year follow-up</time_frame>
    <description>Inflammation change of the internal carotid artery assessed by the Standardized Uptake Value (SUV) obtained with 18FDG-PET scan at one-year follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Target-to-Background Ratio (TBR) of the internal carotid artery</measure>
    <time_frame>Baseline and at one year follow-up</time_frame>
    <description>Inflammation change of the internal carotid artery assessed by the Target-to-Background Ratio (TBR) obtained with 18FDG-PET scan at one-year follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Endothelial Progenitor Cells Count</measure>
    <time_frame>Baseline and at one year follow-up</time_frame>
    <description>Change in the Endothelial Progenitor Cells Count by flow cytometry</description>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Stroke</condition>
  <condition>Inflammation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients diagnosed of ischemic stroke presenting at least on atherosclerotic plaque
        in the internal carotid artery ipsilateral to stroke
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemic stroke within 7 days before inclusion

          -  At least one atherosclerotic plaque in the internal carotid artery

          -  &gt;18 years old

        Exclusion Criteria:

          -  Cardioembolic strokes according to TOAST criteria

          -  Poor functional outcome (Rankin &gt;3) after stroke
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pol Camps-Remom, MD</last_name>
    <phone>+34660030907</phone>
    <email>pcamps@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pol Camps-Renom, MD</last_name>
      <phone>+34660030907</phone>
      <email>pcamps@santpau.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>July 12, 2017</last_update_submitted>
  <last_update_submitted_qc>July 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

